Promacta Improves Platelet Count, Transfusion Independence in MDS
Promacta tended to boost platelet counts in patients with low-risk MDS, and helped those patients be independent of transfusions, too.
Read More
Adding Cabometyx to Immunotherapy Improves Kidney Cancer Outcomes
The addition of Cabometyx to Opdivo and Yervoy improved outcomes for patients with advanced kidney cancer, according to recent research.